Recurrent adult-type granulosa cell tumor of the ovary: A case report

Adult ovarian granulosa cell tumors (AGCTs) are among the most common types of gonadal sex cord-stromal tumors. This pathological entity is generally associated with a favorable prognosis but only accounts for about 2–5% of all malignant ovarian tumors. Disease stage is the most important prognostic factor, with patients diagnosed at an early stage exhibiting a good prognosis. Surgery remains the cornerstone of treatment, both for primary and recurrent cases, while chemotherapy is typically reserved for inoperable or advanced progressive situations. Despite treatment, about one-third of patients experience relapse or progression within 4–7 years, and approximately 50% of these cases result in mortality. We report a case of recurrent AGCT occurring three years after initial surgery and chemotherapy. The patient underwent secondary cytoreductive surgery for recurrent lesions, with postoperative recovery achieved. Further chemotherapy will be administered based on clinical condition and treatment response.

Authors

Publication Details

Journal
Advances in Radiotherapy & Nuclear Medicine
Published
2025-09-23
DOI
https://doi.org/10.36922/arnm025240029
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recurrent adult-type granulosa cell tumor of the ovary: A case report

Khoa Mai Trong, Hai Ha Pham Thi, Thai Pham Van, Phuong Pham Cam et al.
Advances in Radiotherapy & Nuclear Medicine
Ovarian cancer diagnosis and treatment
article

Recurrent adult-type granulosa cell tumor of the ovary: A case report

Khoa Mai Trong, Hai Ha Pham Thi, Thai Pham Van, Phuong Pham Cam, Hưng Nguyễn Thành, Khiem Nguyen Thanh, Nguyễn Thị Diệu Thúy, Ha Le Thanh, Khuy Doan Minh, Lanh Pham Minh
article en

Abstract

Adult ovarian granulosa cell tumors (AGCTs) are among the most common types of gonadal sex cord-stromal tumors. This pathological entity is generally associated with a favorable prognosis but only accounts for about 2–5% of all malignant ovarian tumors. Disease stage is the most important prognostic factor, with patients diagnosed at an early stage exhibiting a good prognosis. Surgery remains the cornerstone of treatment, both for primary and recurrent cases, while chemotherapy is typically reserved for inoperable or advanced progressive situations. Despite treatment, about one-third of patients experience relapse or progression within 4–7 years, and approximately 50% of these cases result in mortality. We report a case of recurrent AGCT occurring three years after initial surgery and chemotherapy. The patient underwent secondary cytoreductive surgery for recurrent lesions, with postoperative recovery achieved. Further chemotherapy will be administered based on clinical condition and treatment response.

Advances in Radiotherapy & Nuclear MedicineVol. 3(4)
Openalex Percentile: Top 66%
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Recurrent adult-type granulosa cell tumor of the ovary: A case report — Khoa Mai Trong, Hai Ha Pham Thi, et al. · Advances in Radiotherapy & Nuclear Medicine (2025) | TGRS Research Map | TGRS